| Net income | 91.92M |
| Depreciation and amortization | 23.09M |
| Stock-based compensation expense | 9.44M |
| Gain on sale of equipment | |
| Deferred income taxes | -3.44M |
| Trade receivables, net | 92.08M |
| Inventories, net | -12.52M |
| Prepaids and other assets | 34.35M |
| Excess tax benefits of stock option exercises | -58K |
| Trade accounts payable and accrued expenses | -13.28M |
| Net cash provided by operating activities | 221.49M |
| Purchase of property, plant and equipment | -20.29M |
| Proceeds from sale of equipment | 281K |
| Net cash used in investing activities | -20.01M |
| Principal payments on debt | |
| Proceeds from exercise of stock options | 940K |
| Excess tax benefits of stock option exercises | 58K |
| Net cash provided by financing activities | -23.24M |
| Effect of exchange rate changes on cash activities | -16.95M |
| Increase in cash and cash equivalents | 161.29M |
| Cash and cash equivalents at beginning of period | 381.34M |
| Cash and cash equivalents at end of period | 542.63M |